Biotechnology

Techseriesinsight > Blog > News > Biotechnology

July 16, 2025
Business Wire
Biotechnology, Healthcare, News

CF Foundation Pledges $24M for Gene Therapy

Today, the Cystic Fibrosis Foundation announced an additional investment of up to $24 million in Prime Medicine to continue the development of a gene editing therapy for people with...

July 14, 2025
Business Wire
Biotechnology, Healthcare, News

Summit Partners Announces Growth Investment in Dreampath Diagnostics to Accelerate Digital Transformation in Anatomical Pathology

Summit Partners today announced a growth investment in Dreampath Diagnostics, a leading healthcare technology company focused on digitizing workflows in anatomical pathology laboratories. The investment will support the company’s plans to...

July 11, 2025
PRNewswire
Biotechnology, News

Angel Yeast Unleashes Visionary, Green Growth With Purpose

Angel Yeast (600298.SH) recently released its 2024 Sustainability (ESG) Report, providing in-depth insights into the company’s thoughts and actions towards sustainable development management. The report highlights significant efforts across key...

July 11, 2025
Business Wire
Biotechnology, Healthcare, News

HCA Healthcare Appoints John W. Chidsey, III as New Independent Director

HCA Healthcare, Inc. (NYSE: HCA), one of the nation’s leading healthcare providers, today announced that its board of directors has appointed John W. Chidsey, III as an independent director, effective...

July 11, 2025
Business Wire
Biotechnology, Healthcare, News

Datavant Completes Acquisition of Aetion

Datavant, a leading health data platform company, today announced the successful completion of its acquisition of Aetion, a leading real-world evidence (RWE) platform that powers critical decision-making in healthcare....

Illustration of stent inside coronary artery

July 10, 2025
Business Wire
Biotechnology, Healthcare, News

XyloCor Doses First Patient in Transformative Gene Therapy Trial

XyloCor Therapeutics, a clinical-stage biopharmaceutical company focused on developing novel therapies for cardiovascular disease, announced the first patient has been dosed in the Phase 2b EXACT-2 trial, designed to...

July 10, 2025
Business Wire
Biotechnology, Healthcare, News

Sinovac’s New Board Holds First Meeting, Elects Andrew Y. Yan as Chairman

Sinovac Biotech Ltd. (NASDAQ: SVA) (SINOVAC or the Company), a leading provider of biopharmaceutical products in China, today announced the new board of directors of the Company (the Board), comprising Mr. Simon...

July 9, 2025
PRNewswire
Biotechnology, News

Zentiva Signs Biosimilar Pact With Lupin

Zentiva Group and global pharmaceutical company Lupin Limited, have entered into a license and supply agreement for commercialization of Lupin’s biosimilar, TNF alpha inhibitor medicine, across multiple markets globally. This...

July 8, 2025
Business Wire
Biotechnology, Healthcare, News

Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, today announced the grant of stock options to purchase 45,000 shares...

July 8, 2025
Business Wire
Artificial Intelligence, Biotechnology, Networking, News

BostonGene Teams Up With SWOG to Drive Precision Cancer Research

BostonGene, a leader in AI-powered solutions for drug discovery and development, today announced a collaboration with the SWOG Cancer Research Network, a global cancer research community that designs and conducts...